Skip to main content

Advertisement

SpringerLink
Log in

Strategies to prevent kidney disease and its progression

  • Comment
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

The 2020 World Kidney Day campaign highlights the importance of prevention of chronic kidney disease. Various strategies and therapies are available to prevent disease before its onset (primary prevention), during early disease stages (secondary prevention) and for effective management of established disease to prevent dialysis (tertiary prevention).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hill, N. R. et al. PLoS One 11, e0158765 (2016).

    Article  Google Scholar 

  2. Bello, A. K. et al. Kidney Int. Suppl. 8, 41–51 (2018).

    Article  Google Scholar 

  3. Bello, A. K. et al. BMJ 367, l5873 (2019).

    Article  Google Scholar 

  4. Li, P. K.-T. et al. Kidney Int. 97, 226–232 (2020).

    Article  Google Scholar 

  5. Kovesdy, C. P. et al. J. Ren. Nutr. 27, 75–77 (2017).

    Article  Google Scholar 

  6. Tantisattamo, E. et al. Kidney Int Rep. 4, 1205–1218 (2019).

    Article  Google Scholar 

  7. Wesseling, C. et al. Environ Res. 147, 125–132 (2016).

    Article  CAS  Google Scholar 

  8. Kalantar-Zadeh, K. & Fouque, D. N. Engl. J. Med. 377, 1765–1776 (2017).

    Article  CAS  Google Scholar 

  9. Rhee, C. M. et al. Curr. Opin. Nephrol. Hypertens. 29, 92–102 (2020).

    Article  Google Scholar 

  10. Murea, M. et al. Kidney Int. Rep. https://doi.org/10.1016/j.ekir.2019.11.014 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension and Kidney Transplantation, University of California Irvine School of Medicine, Orange, California, USA

    Kamyar Kalantar-Zadeh

  2. Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China

    Philip K.-T. Li

Authors
  1. Kamyar Kalantar-Zadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip K.-T. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kamyar Kalantar-Zadeh.

Ethics declarations

Competing interests

K.K.-Z. has received honoraria and/or support from Abbott, Abbvie, ACI Clinical (Cara Therapeutics), Akebia, Alexion, Amgen, AstraZeneca, Aveo, BBraun, Chugai, Cytokinetics, Daiichi, DaVita, Fresenius, Genentech, Haymarket Media, Hospira, Kabi, Keryx, Kissei, Novartis, Pfizer, Regulus, Relypsa, Resverlogix, Sandoz, Sanofi, Shire, Vifor, UpToDate and ZS-Pharma. P.K.-T.L. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalantar-Zadeh, K., Li, P.KT. Strategies to prevent kidney disease and its progression. Nat Rev Nephrol 16, 129–130 (2020). https://doi.org/10.1038/s41581-020-0253-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41581-020-0253-1

  • Springer Nature Limited

This article is cited by

Search

Navigation